Novel camptothecin derivative, composition comprising same and use thereof
AssigneeWigen Biomedicine Technology (Shanghai) Co., Ltd.
InventorsYuli XIE, Gang CAO, Houxing FAN, Lihui QIAN
Life of this patent
Estimating the term…
Abstract
The present invention provides a camptothecin derivative, a composition comprising the same and use thereof. Specifically, the present invention provides a compound of formula (1) and a preparation method therefor, and use of the compound of general formula (1) and optical isomers, crystalline forms and pharmaceutically acceptable salts thereof in the preparation of a medicament for treating cancer.
Claims18
A camptothecin derivative compound of general formula (1) or optical isomers, crystalline forms, pharmaceutically acceptable salts, hydrates or solvates thereof:
- wherein, in general formula (1):
- m is an integer of 0, 1 or 2;
- X is selected from —O—, —S—, —S(O)—, —S(O2)—, and —N(R4)—;
- R1 and R2 are independently selected from H, halogen, OH, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C3-6 cycloalkyl, NH2, NO2, and CN, or R1 and R2, together with the phenyl ring attached thereto, form
- by cyclization;
- R3 is selected from C1-6 alkyl, C2-6 alkenyl, C1-3 alkoxy-substituted C1-3 alkyl, and C1-6 haloalkyl;
- R4 is selected from H, C1-6 alkyl and C1-6 haloalkyl;
- R5 is selected from H, C1-6 alkyl and C3-6 cycloalkyl;
- R6 and R7 are independently selected from H, C1-6 alkyl, C1-6 haloalkyl, and C3-6 cycloalkyl;
- or
- R6 and R7, together with the carbon atom attached thereto, form C3-6 cycloalkyl or 4-7 membered heterocycloalkyl by cyclization;
- or R6 and R5 are linked to form a 5-7 membered lactam ring, and R7 is selected from H, C1-6 alkyl, C1-6 haloalkyl, and C3-6 cycloalkyl;
- R8 is selected from OH and NR9R10, and R9 and R10 are independently selected from H, C1-6 alkyl and C3-6 cycloalkyl;
- or R9 and R10, together with the N atom attached thereto, form 4-7 membered heterocycloalkyl by cyclization, and the 4-7 membered heterocycloalkyl is unsubstituted or substituted with 1-3 groups selected from the following:
- C1-6 alkyl, halogen, OH, CN, and NH2.
A camptothecin derivative compound or optical isomers, crystalline forms, pharmaceutically acceptable salts, hydrates or solvates thereof, wherein the compound has one of the following structures:
A camptothecin derivative compound or optical isomers, crystalline forms, pharmaceutically acceptable salts, hydrates or solvates thereof, wherein the compound has one of the following structures:
Dependencies are inferred from the claim text.